Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-053910
Filing Date
2012-11-19
Accepted
2012-11-19 20:26:53
Documents
1
Period of Report
2012-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2093
  Complete submission text file 0001209191-12-053910.txt   3712
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address
Errington Jeffery (Reporting) CIK: 0001560865 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35285 | Film No.: 121216288